Literature DB >> 26702748

The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.

Mohammad-Sadegh Fallah1, Bahareh Sedaghatikhayat2, Kamran Guity2, Fereshteh Akbari2, Fereidoun Azizi3, Maryam S Daneshpour4.   

Abstract

INTRODUCTION: Metabolic syndrome (MetS) is a multi-factorial disorder with five important components. A high triglyceride level combined with low HDL cholesterol has been reported to be associated with Apolipoprotein A5 (APOA5) gene variations. In this study, we aimed to determine the association of single nucleotide polymorphisms including: rs662799, rs3135506 and rs2075291 in the apolipoprotein A-V (APOA5) gene in relation to MetS component like triglyceride and HDL-C level in Tehran Lipid and Glucose Study (TLGS).
MATERIALS AND METHODS: Metabolic syndrome was defined according to ATPIII and phenotypes were defined by the National Cholesterol Education Program (NCEP) criteria for MetS. Demographic, biochemical parameters and anthropometric variables were measured. Selected APOA5 gene polymorphisms were genotyped using PCR-RFLP method.
RESULTS: From TLGS population, 947 adults, aged 19 - 70 years, were randomly selected and recruited into the study. Mean age, triglyceride and WC were higher and mean HDL was lower in MetS vs. non-MetS group. C allele in rs2075291 showed a significant association with MetS (OR: 2.38, 95% CI; 1.11 - 5.08, P = 1.5 ×10(-2)). The association was shown between higher serum triglyceride and the presence of T allele (P = 4.5 × 10(-4)) and also lower serum HDL-C and the presence of T allele (P = 1.6 × 10(-3)) in rs2075291. Also this association showed between raised waist circumference and C allele in rs3135506 (P = 3.5 × 10(-2) ) and raised systolic and diastolic blood pressure level and C allele of rs662799 (P = 4.5 × 10(-2)).
CONCLUSION: According to the results, there is a relationship between lipid profile and studied polymorphism in the presence of metabolic syndrome. It seems that APOA5 rs2075291 could play an important role in triglyceride and HDL-C level in metabolic syndrome affected, while the association of APOA5 rs662799 polymorphism is still under debate.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26702748     DOI: 0161901/AIM.009

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  9 in total

Review 1.  Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.

Authors:  Montse Guardiola; Josep Ribalta
Journal:  Curr Atheroscler Rep       Date:  2017-07       Impact factor: 5.113

2.  Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population.

Authors:  Eugene Lin; Po-Hsiu Kuo; Yu-Li Liu; Albert C Yang; Chung-Feng Kao; Shih-Jen Tsai
Journal:  Sci Rep       Date:  2016-11-09       Impact factor: 4.379

3.  Identification of a New Single-nucleotide Polymorphism within the Apolipoprotein A5 Gene, Which is Associated with Metabolic Syndrome.

Authors:  Samaneh Salehi; Modjtaba Emadi-Baygi; Majdaddin Rezaei; Roya Kelishadi; Parvaneh Nikpour
Journal:  Adv Biomed Res       Date:  2017-03-07

4.  Prevalence of metabolic syndrome and health-related quality of life in war-related bilateral lower limb amputees.

Authors:  Hanieh-Sadat Ejtahed; Mohammad-Reza Soroush; Shirin Hasani-Ranjbar; Pooneh Angoorani; Batool Mousavi; Mehdi Masumi; Farhad Edjtehadi; Mahmood Soveid
Journal:  J Diabetes Metab Disord       Date:  2017-04-05

5.  Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: a meta-analysis in North Africa.

Authors:  Meriem Hechmi; Hamza Dallali; Meriem Gharbi; Haifa Jmel; Meriem Fassatoui; Yossra Ben Halima; Sonia Bahri; Afaf Bahlous; Abdelmajid Abid; Henda Jamoussi; Abdelhamid Barakat; Rym Kefi
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

Review 6.  Genetic Identification for Non-Communicable Disease: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Maryam S Daneshpour; Mehdi Hedayati; Bahareh Sedaghati-Khayat; Kamran Guity; Maryam Zarkesh; Mahdi Akbarzadeh; Niloofar Javanrooh; Azita Zadeh-Vakili; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2018-10-27

7.  Kernel machine SNP set analysis finds the association of BUD13, ZPR1, and APOA5 variants with metabolic syndrome in Tehran Cardio-metabolic Genetics Study.

Authors:  Sajedeh Masjoudi; Bahareh Sedaghati-Khayat; Niloufar Javanrouh Givi; Leila Najd Hassan Bonab; Fereidoun Azizi; Maryam S Daneshpour
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Detection of susceptibility loci on APOA5 and COLEC12 associated with metabolic syndrome using a genome-wide association study in a Taiwanese population.

Authors:  Eugene Lin; Po-Hsiu Kuo; Yu-Li Liu; Albert C Yang; Shih-Jen Tsai
Journal:  Oncotarget       Date:  2017-09-16

9.  Associations of Polygenetic Variants at the 11q23 Locus and Their Interactions with Macronutrient Intake for the Risk of 3GO, a Combination of Hypertension, Hyperglycemia, and Dyslipidemia.

Authors:  Jun-Yu Zhou; Sunmin Park
Journal:  J Pers Med       Date:  2021-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.